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ABSTRACT Gene amplification may be visualized within a
chromosome as a homogeneously stained region (HSR) and HSRs
have rarely been reported in human tumor cells with identification
of the amplified gene. A parental line and seven clones derived
from KB cells resistant to methotrexate (MTX) contain dihydro-
folate reductase (DHFR; tetrahydrofolate dehydrogenase; EC
1.5.1.3), ranging from 0.007 unit/mg in the parent to 0.369 unit/
mg in clone 7A with a 13,000-fold increase in resistance to MTX.
The enzyme is identical to DHFR from other human sources, in-
cluding that from leukemic patients. A HSR localized to the long
arm of chromosome 10(q26) is present in clones selected at or
above 2.5 jaM MTX. Increase in number of 10q per cell, increase
in number of HSR, and increasing amounts of DHFR correlate
well. The chromosome change is stable with time as is enzyme
production even in the absence of selection by MTX. No clone has
shown double minutes. The gene copy number is low. The stability
and low gene copy in the presence of large HSRs differ from the
pattern described for murine tumors. A human gene for DHFR
may be associated with the long arm of chromosome 10.
Gene amplification is inducible in mammalian cells by incre-
mental exposure to cytotoxic drugs and is often accompanied
by the appearance of anomalous chromosomes. Resistance to
methotrexate (MTX) by overproduction ofdihydrofolate reduc-
tase (DHFR; tetrahydrofolate dehydrogenase; EC 1.5.1.3) re-
sults from amplification of the DHFR gene copy number in
murine cells (1). A chromosomal entity, the homogeneously
stained region (HSR), has sometimes been observed in associ-
ation with drug resistance (2) and shown to be the site of gene
amplification (3). Another chromosomal counterpart of ampli-
fied gene function is the double minute chromosome fragment
(DM), a structural alternative to the HSR within a cell popu-
lation (4). The DM lacks a centromere and is unstable, whereas
the HSR, integrated into a centric chromosome, replicates and
segregates normally with cell division (5). Both chromosomal
anomalies have been observed in human tumor cells, usually
without precise identification of the gene product (2, 6).
We have induced HSR formation in a human tumor-derived
cell line by exposure to increasing concentrations of MTX. We
found a quantitative relationship between increased DHFR
production and a series ofchromosomal events which included
both numerical and structural modifications. The region of gain
and HSR formation suggests possible localization for a human
DHFR gene (dhfr). The stability of drug resistance and rela-
tively low gene copy numbers associated with HSR in these
human cells differ from results in rodent cell systems (7, 8).
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MATERIALS AND METHODS
The KB line, originally derived from an oral carcinoma, now
appears to be a HeLa contaminant, based upon enzymic and
cytogenetic markers (9). Parental KB cells can survive exposure
to 0.01 pM MTX. Mass cultures were exposed to 0.1 .tM MTX
for over 6 weeks; the survivors were selected subsequently by
stepwise exposure to 3-fold increments of MTX. Clones, de-
rived from mass culture by isolation with cloning rings, were
selected at concentrations shown in Table 1; DHFR was mea-
sured as in ref. 10. Metaphase preparations, obtained 24-48 hr
after subculture, were stained with aceto-orcein for DMs and
by standard methods for G, Q, and C banding.
Probes were prepared from pDHF 26 plasmid DNA (kindly
provided by R. T. Shimke), restricted with Pst I to obtain the
DHFR cDNA insert. This was then restricted with Bgl II to
obtain the 675-base pair DNA, a fragment corresponding to the
coding region of the mRNA (11). These fragments were sepa-
rated on agarose and polyacrylamide gels: isolation ofrestriction
fragments was performed by electroelution onto dialysis mem-
branes for agarose gels (12) and then by excision and elution
(13) for polyacrylamide gels.
For estimation of DNA copy numbers, high molecular
weight DNA was extracted from the cells by protease K treat-
ment and phenol/chloroform extraction (14). Known amounts
(at least three different amounts for each DNA, ranging from
0.2 to 4 jig) were heat-denatured and spotted onto nitrocellu-
lose paper (15). Hybridization with the 32P-labeled probe was
performed at 650C for 16 hr in 0.9 M NaCl/3 mM NaH2PO4,
pH 7.0/0.3 mM EDTA/0.5% NaDodSO4 with a 20-fold excess
of bacteriophage T4 DNA added (16). After autoradiography,
squares of nitrocellulose corresponding to the spots were as-
sayed for radioactivity in a Beckman LS100 C scintillation
counter. Hybridizations were done with 32P-labeled, nick-
translated DNA from the JW/02 human ,-globulin cDNA clone
for accurate estimation ofDNA concentration and these values
were used as controls. Copy number values are reported on the
basis of 1 for KB parental DNA.
RESULTS AND DISCUSSION
Clones growing in increased concentrations of MTX produce
increased amounts of DHFR (Table 1). The DHFR isolated
from clone 6B is identical to enzyme from the parental KB line
and to enzyme freshly isolated from human leukemia (acute
myelocytic) cells. Its Mr is 20,000, it forms a single band in
Abbreviations: MTX, methotrexate; DHFR, dihydrofolate reductase;
dhfr, dihydrofolate reductase gene; HSR, homogeneously stained re-
gion in chromosome; DM, double minute chromosome fragment; q,
longer arm of a bi-armed chromosome.
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Table 1. Properties of MTX-resistant KB sublines
Chromosomes*
MTX Modal
Cell Conc., Relative DHFR, chromosome
line 1AM resistance unit/mgt no. (range) HSR l0q*
Parent - 1 0.007 78 (59-78) None 3
2D 0.25 10 0.066 71 (51-72) None 3-4
4A 2.5 600 0.160 68 (58-71) 1 3
6A 25 6,500 0.331 70 (60-72) 2 4-5
6B 25 0.284 69 (66-70) 2 4-5
6C 25 0.309 69 (66-73) 2 4
6D 25 0.279 70 (61-73) 2 4
7A 75 13,000 0.369 71 (59-72) 2-4 4-6
* Twenty to forty (or more) cells analyzed per clone.
t Measured after 2 weeks or more in MTX-depleted medium.
* In all but clone 2D (see text), these values represent the intact chro-
mosome 10 per cell.
NaDodSO4 gel, and the specific activity after purification is 60
units/mg of protein (10). Each clone, judged by NaDodSO4
electrophoresis, shows no apparent differences in protein pro-
file except for DHFR. Kinetic properties of enzyme from the
three sources are identical in substrate utilization, MTX bind-
ing, and isoelectric focusing (at pH 7.3). In these respects this
DHFR differs from murine DHFR derived from the S 180 line
(10). Therefore, the resistant clones of KB appear to produce
increased amounts of unaltered human DHFR.
The uncloned parental karyotype is near triploid with several
well-known HeLa marker chromosomes (17). Many chromo-
somal rearrangements have resulted from breakage and recom-
bination at or near centromeres. The least resistant clone (2D)
did not contain a HSR. The localization of a HSR in the long
arm (q) of chromosome 10 at higher levels of MTX resistance
suggested analysis for numerical increases in this region in clone
2D. Karyotypic analysis of 20 parental cells revealed a pair of
chromosome 10 in 3 cells and trisomy for chromosome 10 in 17
cells. No recombinants involving the 10q were identified in the
parent or any clone other than 2D. Despite a lower modal chro-
mosome number than the parent line (Table 1), clone 2D
showed an absolute increase in copies of lOq. Intact chromo-
some 10 were present in one to four copies per cell; in addition,
in each cell there were one or two copies of a recombinant in
which the p arms resembled an llq and the q arms were iden-
tifiable as 10q. The average number of 10q copies in 24 cells
from clone 2D was 3.6, in contrast to an average below 2.9 for
the parent. A 10-fold increase in MTX resistance resulted in the
appearance in cells of clone 4A of a single, otherwise normal,
chromosome 10 with a HSR in the region 10q26. All clones
isolated in 25 AM MTX contained a large metacentric marker
with two HSRs (Fig. 1). The arms are mirror images of one an-
other, suggesting that the marker arose by isochromosome for-
mation (misdivision at the centromere) (18). C banding dem-
onstrated two small centromeric masses, each similar to that of
a normal chromosome 10 from the same cell. At the highest
concentration studied (clone 7A), an additional HSR-bearing
chromosome was found. At this exposure the generation time
was prolonged and increased numbers of chromosome breaks
were observed.
Because there is intercellular variation in chromosomal con-
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FIG. 1. Karyotype from clone 6B grown in 25 ,M MTX. The large marker is shown next to a pair of normal chromosome 10. The proximal portion
of each arm resembles lOq in band position and stain intensity. Two HSRs (arrows), characteristically pale staining withG orQbanding, are located
distally at positions 1Oq26. A faint repeated banding is evident within the HSRs. Several well-known HeLa markers and other recombinant chro-
mosomes are shown in the bottom line.
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traction, an intracellular reference was developed to obtain rel-
ative measures of the amount ofHSR in each clone. A ratio was
obtained by dividing the cumulative length of the HSR regions
of an individual cell by the average length of the lq arms from
the same cell. The length of the HSR remained constant,
whereas the numbers of HSR increased (Table 2) and the
amount of enzyme was proportional to the relative length of
HSR per clone (see Tables 1 and 2).
Clone 6B has been cultured for over 14 months in MTX-free
medium. In the presence of MTX, DHFR is found in both
bound and free forms. With removal of cells into MTX-free
medium the enzyme level stabilizes at approximately 1/4 ofthe
original value within 2 weeks; the higher value is restored within
3 days of reexposure to MTX (19). DMs are rare in these cul-
tures; only one cell with a DM was found in 100 metaphases of
clone 6B 8 months after MTX depletion. The HSR-bearing
chromosome was present in every cell and its size was un-
changed (Table 2). The level of DHFR was identical to that
found within 2 weeks after depletion. Thus, the amplified gene
appears to be stable with time, both in function and with respect
to chromosomal integration.
Hybridizations in situ by methods used in identification of
mouse dhfr genes (20) were unsuccessful. The same mouse
probe that codes for mouse DHFR with over 90% homology to
the human DHFR (21) was used to estimate gene copy number.
DNA extracts of clone 6B showed a 9-fold increase over the
parent in ability to hybridize with the mouse probe on nitro-
cellulose. Thus, less than five gene copies are estimated to cor-
respond to each HSR. Corroborative data on other clones have
been obtained (22).
Chromosomal events provided means for increase in a spe-
cific subchromosomal region coincident with increasing drug
resistance. The apparent sequence in these experiments began
with increase in the number of chromosomes (no. 10) or partial
chromosomes (10q) presumed to bear relevant information. As
drug resistance increased, a HSR appeared (10q26), followed
by formation of an isochromosome, doubling the HSR, and fi-
nally, selection for additional HSR-bearing chromosomes.
The assignment ofa human dhfr to the HSR locus is tentative
for several reasons. Localization of amplified dhfr genes in the
hamster is not entirely uniform (8). It has been suggested that
Table 2. Relative HSR lengths
HSR/lq
Clone MTX* HSR, no. Ratio Range
4A + 1 1.01 (0.90-1.17)
6A + 2 2.06 (1.64-2.23)
6C + 2 2.33 (2.20-2.49)
6D + 2 2.25 (2.61-2.55)
7A + 2-4 3.23 (2.17-4.14)
6B + 2 2.40 (2.30-2.56)
6Bt _ 2 2.57 (2.36-3.24)
6B* - 2 2.64 (2.11-3.08)§
6BI - 2 2.61 (2.48-2.75)
Relative HSR length measurements were based on 5-20 cells per
clone.
* MTX-containing (+) and MTX-free (-) culture medium.
t Three weeks in MTX-free medium.
* Eight weeks in MTX-free medium.
§ One cell, with an additional (tandem repeat) HSR, showed a ratio of
4.27.
Eight months in MTX-free medium.
gene amplification occurs in chromosomal fragments followed
by reintegration, not necessarily at the native gene location (23).
An MTX-resistant human leukemia line is marked by HSRs on
two different (no. 6 and no. 19) chromosomes (although its en-
zymic properties are not fully defined) (24). Furthermore, the
human dhfr family is complex and probably includes four loci
(25).
In other species massive increases in gene copy (50- to 200-
fold) accompany HSR formation (26). The amplified murine unit
is known to be much larger in size than the dhfr (20, 27), but
the discrepancy between the number of gene copies and the
amount of HSR is much greater in this human system than has
been described previously.
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